HOB Biotech Group Corp Ltd Capital Reinvestment Ratio
HOB Biotech Group Corp Ltd capital reinvestment ratio. HOB Biotech Group Corp Ltd (688656) has a Capital Reinvestment Ratio of 0.56x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.28 Million) in capital expenditures (CN¥8.50 Million). See HOB Biotech Group Corp Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of HOB Biotech Group Corp Ltd (2016–2025)
Capital reinvestment ratio of HOB Biotech Group Corp Ltd from 2016 to 2025. This chart tracks HOB Biotech Group Corp Ltd's Capital Reinvestment Ratio across 10 annual periods. See HOB Biotech Group Corp Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
HOB Biotech Group Corp Ltd Capital Reinvestment Ratio by Year (2016–2025)
HOB Biotech Group Corp Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see 688656 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | CN¥72.94 Million | CN¥73.90 Million | ▼ -34.0% |
| 2024 | 1.53x | CN¥101.22 Million | CN¥155.37 Million | ▼ -11.5% |
| 2023 | 1.73x | CN¥102.69 Million | CN¥178.03 Million | ▼ -54.1% |
| 2022 | 3.78x | CN¥58.31 Million | CN¥220.21 Million | ▲ +135.7% |
| 2021 | 1.60x | CN¥104.79 Million | CN¥167.89 Million | ▲ +63.6% |
| 2020 | 0.98x | CN¥58.22 Million | CN¥57.01 Million | ▲ +93.0% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥34.80 Million | ▼ -11.5% |
| 2018 | 0.57x | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥6.42 Million | CN¥17.15 Million | — |